Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
14,484 total articles
Bullish's announced $4.2B acquisition of Equiniti and steady institutional buying have shifted the stock from distressed crypto play to an offensive growth opportunity. With the combined business targeting $1.3B in 2026 revenue and $500M+ adjusted EBITDA, Bullish now trades like a scaled fintech growth name. This trade idea upgrades Bullish to a bu…
Eastern Bankshares (EBC) has moved from regional underdog to a scaled New England franchise after the HarborOne deal. Integration tailwinds, low leverage and a sub-1.1 price-to-book make this a pragmatic, asymmetric trade. We upgrade to a buy for a mid-term (45 trading days) trade with a clear entry, stop and target.
Remitly (RELY) finished 2025 with accelerating top-line momentum, positive free cash flow and a $1.48B cash balance. Management is pushing beyond pure remittances into broader financial services and SMB payment flows. At a $5.06B market cap and an enterprise value of roughly $4.41B, the risk/reward looks attractive if SMB monetization scales. This …
Gartner (IT) has retraced sharply from a $451 52-week high to $158.65 today, trading at roughly $10.6B market cap with FCF of ~$1.26B and an EV/EBITDA near 8.5. That combination puts the stock in value territory and offers a tactical long opportunity for patient, risk-aware investors. The trade here is contingent on a stabilization in contract and …
TETRA Technologies (TTI) is a cash-generating oilfield services name trading at $9.78 where improving activity, specialty-chemical exposure (bromine) and clean water management services create a multi-front catalyst runway. Valuation looks reasonable on an EV/EBITDA basis but stretched on P/E because of low EPS; this creates a scenario where operat…
Red Rock Resorts beat on earnings in Q1 driven by strong visitation and spend per visit, but revenue pressure and elevated costs keep the stock muted. At roughly $54.50 today, the stock offers a reasonable entry for a patient, long-term trade: attractive EV/EBITDA, solid free cash flow, and a track record of development-led growth. The trade is a d…
Global Partners (GLP) offers a rare blend of yield, free cash flow and reasonable valuation in a capital-intensive fuel-distribution business. At $48.75 the unit trades at an attractive P/FCF of 8.5 and EV/EBITDA of 8.9, with a 6%-plus yield and $193M in free cash flow backing distributions. We upgrade GLP and outline a mid-term (45 trading days) t…
CVS is trading near a fresh 52-week high after earnings and better-than-expected medical cost trends. Valuation metrics on a price-to-sales and EV basis remain attractive for a company with $7.4B in free cash flow and a meaningful dividend. This trade idea outlines a mid-term swing-long with entry at the market, a disciplined stop and a realistic t…
Advanced Micro Devices has ridden the AI wave to a dramatic rerating. With Q1 data-center growth at 57%, clean balance sheet metrics, and free cash flow of $8.57B, a $700 target inside 180 trading days is a reasonable bullish trade. This note lays out why $600 is likely too low, the valuation math, catalysts to watch, and a concrete trade plan with…
Novo Nordisk’s Q1 beat and the blockbuster uptake of the Wegovy pill give the stock room to re-rate. With reported Q1 sales of $15.17B, guidance raised to $42.39-$46.24B, and more than 2 million Wegovy prescriptions since launch, the company is pivoting from price-driven headwinds to volume-led growth. Valuation (market cap ~$209B, P/E ~10.8) leave…
Credo Technology trades at premium multiples today, but the company's move into silicon photonics via the DustPhotonics acquisition and continued data-center connectivity momentum create a plausible path for significant revenue and profit upside. This is a long trade with clear entry, stop, and target levels tied to expected catalyst delivery over …
Angel Studios has a differentiated crowdsourced content model and an active pipeline of licensed and self-produced titles. With multiple monetization levers still scaling — ad-supported streaming, theatrical/streaming windowing and licensing — the stock looks attractive for a measured long with clear risk controls. This trade idea lays out entry, s…
Apple's device+services moat positions it to monetize AI in a uniquely high-margin way. With a $4.3T market cap, $129B of free cash flow and industry-leading returns on capital, the stock is richly priced but offers an asymmetric payoff if Apple converts AI features into recurring paid services. This trade is a long position sized for conviction wi…
I previously took a tougher stance on NBXG but recent price action, improving technicals, and a high annualized distribution have me upgrading to a buy for a defined swing trade. Entry $15.30, stop $14.45, target $17.00 over the next 45 trading days.
Riot Platforms is transitioning from pure bitcoin mining to a hybrid business that includes AI-focused data center development. Fundamentals show aggressive growth in hash-rate capacity, a $9.1B market cap, and strategic land/partner deals with AMD, but the stock is technically extended. We upgrade to a long-term buy and recommend entering on a dis…
Keysight supplies test, measurement and validation tools that data center, telecom and semiconductor customers need to deploy reliable AI hardware at scale. With AI-related revenue accelerating, strong free cash flow and a defensive defense/government business, Keysight offers a high-conviction swing trade. Valuation is rich, so execute with define…
UiPath is carving a defensible niche as the enterprise agentic-AI execution layer. The stock is trading at a modest multiple after a sell-off that pushed it near its 52-week low. With GAAP profitability, strong free cash flow, and an EV/S near 3.0, this is a measured long with a clear entry, stop and target for a mid-term trade.
Cerus (CERS) looks like a validated turnaround after recent results and follow-through in price and volume. The company still carries execution risk and a stretched valuation relative to profitability, but the combination of rising demand for INTERCEPT systems, a cleaner cash runway and a surge in short interest sets up a trade with asymmetric upsi…
Verizon is trading near $47 with a 5.9% yield, healthy free cash flow of $20.3B, and improving subscriber and EBITDA momentum. The stock looks attractively valued at ~11x earnings and ~7.5x EV/EBITDA. For income-focused traders who also want upside, a mid-term swing trade into $52.50 with a $44 stop provides a favorable risk/reward while preserving…
Eli Lilly reported explosive top-line and EPS growth driven by its GLP-1 franchise and pipeline momentum. With rumored incremental 2026 revenue upside, a clean safety profile on key non-GLP assets and free cash flow of roughly $11.8B, LLY looks set for further appreciation. This trade idea lays out a clear entry, stop and target across a position-l…
Krystal Biotech's marketed product VYJUVEK has put the company on the map and produced strong revenue in 2025, but investors are underpricing the optionality from multiple gene-therapy programs with near-term catalysts. With solid cash on the balance sheet, positive free cash flow, and a suite of presentations and readouts ahead, KRYS is a buy for …
Comcast (CMCSA) trades at $25.44 with a headline dividend yield near 5.2%, but the company is generating roughly $20.4B in free cash flow against a $90.7B market cap. That math implies an equity-level cash generation capacity that could support materially higher capital returns. This trade idea buys the dip with a clear entry, stop and target and a…
Dell is trading near its 52-week high after a big gap higher, driven by AI supercomputer deals and improving ISG dynamics. Valuation is full by several measures and momentum is stretched, but cash generation ($8.55B FCF) and meaningful enterprise exposure make a scaled, risk-defined long sensible for a swing trade. Entry $255, stop $235, target $30…
Siemens Healthineers' recent carve-out announcement simplifies the business mix and should improve capital allocation and multiples over the next several quarters. We recommend a tactical long position sized for a medium-term hold, with a clear entry at $50.00, stop at $42.00 and a primary target of $60.00. Risks include execution on the carve-out,…
Nutrien (NTR) is a high-quality crop nutrient platform trading at a modest P/E and a 3.2% yield while sitting squarely in the path of a global fertilizer supply squeeze. The market is discounting Fertilizer cyclicality more than the durable demand drivers, creating an asymmetric trade - income today and meaningful upside if supply dynamics persist.
